Objective Despite the establishment of transcatheter closure as the treatment of choice in
adults with secundum atrial septal defects (ASDs), the effectiveness of this approach in the …

The left atrial appendage closure (LAAC), the efficacy and safety of which has been proved
by a number of randomized controlled trials and registries, is recommended by several …

Objectives The long-term outcomes after transcatheter closure of atrial septal defects (ASD)
in adults are reported and compared between age groups and against population control …

Objective To evaluate the frequency of and risk factors for stroke as a presenting feature in
adult patients with secundum atrial septal defect (ASD); rates of post-closure atrial fibrillation …

Objective. We reported the 3‐year follow‐up results of initial clinical experience with the
AbsnowTM device, a novel biodegradable occluder for percutaneous closure of atrial septal …

Aims The optimal antiplatelet therapy after atrial septal defect (ASD) or patent foramen ovale
device closure (PFO) remain to be established. We evaluated the safety and effectiveness of …

Objective To evaluate the feasibility, safety, and effectiveness of a novel, absorbable atrial
septal defect (ASD) closure device made of poly‐l‐lactic acid (PLLA) in a swine model of …

Purpose Atrial fibrillation (AF) often coexists with atrial septal defects (ASD). Each of the
transcatheter closure for ASD and radiofrequency catheter ablation (RFCA) for AF have …

Even cardiac surgery has been accepted as the standard therapy for Lutembacher
syndrome, a combination of congenital ostium secundum atrial septal defect (ASD) and …

The field of adult congenital interventions is unique in the world of cardiac catheterization,
combining the structural concepts commonly employed in pediatric heart disease and …